Dense gas anti-solvent processes for pharmaceutical formulation
Source abstract
Abstract
Conventional processes for manipulating the characteristics of particles used in drug formulation are limited in their flexibility. Recent studies in which supercritical/dense gas processes have been used for particle design and drug formulation show considerable promise. These developing dense gas technologies for drug formulation are described in this review. Issues relating to scale up on dense gas technology application for pharmaceutical active are also identified.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Phase Equilibria and Thermodynamics · Analytical Chemistry and Chromatography · Crystallization and Solubility Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (73)
Show source-provided references
1. On the solubility of solids in gases10.1098/rspl.1879.0054 ↗
2. Micronisation by rapid expansion of Supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals10.1021/ie000151a ↗
3. Micronisation of copper indomethacin using gas anti-solvent processes10.1021/ie010760y ↗
4. Synthesis, purification, and micronisation of pharmaceuticals using the gas anti-solvent technique10.1021/ie000189n ↗
5. Application of dense gas techniques for the production of fine particles10.1208/ps050211 ↗
6. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process10.1021/js960136o ↗
7. Processing pharmaceutical compounds using dense-gas technology10.1021/ie030219x ↗
8. Jung J, Leboeuf F, Francais E, Perrut M. Drug delivery systems: manufacture using supercritical fluids. In: Proceedings––28th International Symposium on Controlled Release of Bioactive Materials and 4th Consumer & Diversified Products Conference, San Diego, CA, United States, June 23–27, 2001;1:842–843
9. Particle design using supercritical fluids: literature and patent survey10.1016/S0896-8446(01)00064-X ↗
10. Solvent effects on the controlled dense gas precipitation of model proteins10.1002/(SICI)1097-4660(200001)75:1<42::AID-JCTB173>3.0.CO;2-C ↗
11. The influence of operating conditions on the dense gas precipitation of model proteins10.1002/(SICI)1097-4660(200001)75:1<29::AID-JCTB172>3.0.CO;2-E ↗
12. De Gioannis BJP, Subra P. Crystallisation of griseofulvin by batch anti-solvent process. In: Proceeding of the 6th International Symposium on Supercritical Fluids. Versailles (France); 2003. p. 1795–800
13. Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterization, and in vitro dissolution10.1016/S0378-5173(01)00711-6 ↗
14. Separation of β-carotene mixtures precipitated from liquid solvents with high-pressure carbon dioxide10.1021/bp00009a011 ↗
15. A fundamental study of the gas anti-solvent process
16. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method10.1002/jps.10186 ↗
17. Subramaniam B, Said S, Rajewski RA, Stella V. Methods and apparatus for particle precipitation and coating using near-critical and supercritical anti-solvents. In: PCT Int Appl; 1997, WO 9731691
18. Richard J. Microparticle engineering for drug delivery using a supercritical fluid-based process: application to injectable sustained-release formulations of biomolecules. Abstracts of Papers, 226th ACS National Meeting, New York, NY, United States, September 7–11, 2003, MSE-409
19. Richard J, Dulieu C, Le Meurlay D, Benoit J-P. Microparticles for pulmonary administration comprising at least a coating agent. In PCT Int Appl; 2001, WO 0112160
20. DELOS process: a crystallization technique using compressed fluids. 1. Comparison to the GAS crystallization method10.1016/S0896-8446(02)00189-4 ↗
21. Depressurization of an expanded liquid organic solution (DELOS): a new procedure for obtaining submicron- or micron-sized crystalline particles10.1021/cg0155090 ↗
22. Ventosa N, Sala S, Veciana J. The DELOS process: A new eco-efficient tool for particle engineering. In: Proceeding of the 8th Meeting on Supercritical Fluids. Borseaux (France); 2002. p. 57
23. Sievers RE, Huang ETS, Villa JA, Walsh TR, Meresman HV. Fine particle manufacturing using supercritical carbon dioxide intimately mixed with aqueous or alcoholic solutions of pharmaceuticals. Abstracts of Papers, 223rd ACS National Meeting, Orlando, FL, United States, April 7–11, 2002, IEC-240
24. Particle design using supercritical fluids10.1002/ceat.200300005 ↗
25. Micronisation of antibiotics by supercritical assisted atomisation10.1016/S0896-8446(02)00162-6 ↗
26. Reverchon E. Process for the production of micro and/or nano particles. In: PCT Int Appl; 2003, WO 03004142
27. Supercritical anti-solvent precipitation of micro- and nano-particles10.1016/S0896-8446(98)00129-6 ↗
28. Applications of supercritical fluids to pharmaceuticals: controlled drug release systems
29. Recent applications of supercritical fluid technology to pharmaceutical powder systems10.14356/kona.2001011 ↗
30. Protein nanoparticles formation by supercritical anti-solvent with enhanced mass transfer10.1002/aic.690480207 ↗
31. Production of griseofulvin nanoparticles using supercritical CO2 anti-solvent with enhanced mass transfer10.1016/S0378-5173(01)00803-1 ↗
32. Micronisation and microencapsulation of pharmaceuticals using a carbon dioxide anti-solvent10.1016/S0032-5910(02)00045-1 ↗
33. Hanna MH, York P. Drug particle formation methods. In: PCT Int Appl; 2002, WO02038127
34. Foster NR, Dehghani F, Bustami RT, Chan HK. Generation of lysozyme–lactose powders using the ASES process. In: Proceeding of the 6th International Symposium on Supercritical Fluids. Versailles (France); 2003. p. 1831–6
35. Pilot scale micronisation of amoxicillin by supercritical anti-solvent precipitation10.1016/S0896-8446(02)00186-9 ↗
36. Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system10.1023/B:PHAM.0000008053.69903.c1 ↗
37. Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide10.1023/A:1007551006782 ↗
38. Perrut M, Jung J, Leboeuf F. Method for obtaining solid particles from a water-soluble product. In: PCT Int Appl; 2002, WO02092213
39. Foster NR, Regtop HL, Dehghani F. Preparation of small particles for pharmaceutical delivery. In: PCT Int Appl; 2003, WO03047553
40. Foster NR, Regtop HL, Dehghani F, Bustami RT, Chan H-K. Synthesis of small particles of biol. active agents, such as pH-sensitive proteins. In: PCT Int Appl; 2002, WO02045690
41. Micronisation of insulin from halogenated alcohol solution using supercritical carbon dioxide as an anti-solvent10.1002/jps.10193 ↗
42. Jung JLF, Perrut M. Preparation of inhalable protein particles by SCF-emulsion drying. In: Proceedings of the 6th International Symposium of Supercritical Fluids, Versailles (France); 2003. p. 1837–42
43. Cussen C. Eiffel Technologies announces breakthrough insulin study, Official Announcment by ASX on 15th August 2002
44. Crystallisation process in turbulent supercritical flows10.1016/S0022-0248(98)01022-7 ↗
45. Elvassore N, Cozzi F, Bertucco A. Modelling of particle formation in supercritical anti-solvent processes: diluted and concentrated regime. In: Proceedings of the 6th International Symposium of Supercritical Fluids. Versailles (France); 2003. p. 1635–40
46. Modeling the gas anti-solvent recrystallisation process10.1021/ie020070+ ↗
47. Kinetics of particle formation in the gas anti-solvent precipitation process10.1002/aic.690490406 ↗
48. Mathematical modeling of nucleation and growth of particles formed by the rapid expansion of a supercritical solution under subsonic conditions10.1016/S0896-8446(01)00134-6 ↗
49. Dillow AK, Langer RS, Foster N, Hrkach JS. Supercritical fluid sterilization method. In: PCT Int Appl; 1999, WO9966960
50. Li J, Thompson GL, Matthews MA, Davis TA. Dense carbon dioxide for cleaning biomaterials: removing S. aureus and bacterial endotoxins. In: AIChE Annual Meeting. San Francisco (CA, USA); 2003
51. Zhang J, Thomas TR, Davis TA, Matthews MA. Sterilization of bacterial spores with high-density carbon dioxide. In: AIChE Annual Meeting. San Francisco (CA, USA); 2003
52. Strategies for particle design using supercritical fluid technologies10.1016/S1461-5347(99)00209-6 ↗
53. Weidner E. Powderous composites by high pressure spray processes. In: Proceedings of the 6th International Symposium on Supercritical Fluids, 28–30 April. Versailles (France); 2003. p. 1483–95
54. Jung J, Clavier J-Y, Perrut M. Gram to kilogram scale-up of supercritical anti-solvent process. In: Proceedings of the 6th International Symposium on Supercritical Fluids, 28–30 April. Versailles (France); 2003. p. 1688–9310.1021/ie030144x ↗
55. Papet S, Marciacq F, Lochard H, Sauceau M, Joussot-Dubien C, Freiss B, et al. Supercritical CO2 anti-solvent process for drugs precipitation: from lab-scale to cGMP compliant pilot-scale. In: Proceedings of the 6th International Symposium on Supercritical Fluids, 28–30 April. Versailles (France); 2003. p. 1689–94
56. Size controlled production of biodegradable microparticles with supercritical gases10.1016/S0939-6411(97)00124-0 ↗
57. Study of the solid state of carbamazepine after processing with gas anti-solvent technique10.1016/S0939-6411(03)00092-4 ↗
58. Foster NR, Ng AS, Dehghani F, Regtop HL. Micronisation of tobramycin using dense gas anti-solvent techniques. In: Proceedings of the 6th International Symposium of Supercritical Fluids. Versailles (France); 2003. p. 1647–52
59. Bustami RT. Application of supercritical fluid technology in micronisation of pharmaceutical compounds, Thesis dissertation in Faculty of Pharmacy, The University of Sydney, 200110.14356/kona.2001011 ↗
60. Micronising of steroids for pulmonary delivery by supercritical carbon dioxide10.1016/S0378-5173(97)00071-9 ↗
61. Debenedetti PG, Lim GB, Prud'Homme RK. Formation of protein microparticles by anti-solvent precipitation, European Patnet, 1993, EP0542314
62. Supercritical fluid processing of proteins. I: Lysozyme precipitation from organic solution10.1016/S0928-0987(00)00108-1 ↗
63. Elvassore N, Bertucco A, Caliceti P. Production of protein-polymer micro-capsules by supercritical anti-solvent techniques. In: Proceedings of the 5th International Symposium on Supercritical Fluids, Atlanta, Georgia; 2000
64. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in d, l PLG microparticles using supercritical fluids10.1016/S0928-0987(99)00079-2 ↗
65. Nam K-W, Lee S, Hwang S-J, Woo JS. Enhancing water-solubility of poorly soluble drug, itraconazole with water-soluble polymer using supercritical fluid processing. In: Controlled Release Society 29th Annual Meeting Proceedings, 2002
66. Meure LA, Warwick B, Dehghani F, Regtop HL, Foster NR. Increasing copper indomethacin solubility by co-precipitation with polyvinylpyrrolidone using the aerosol solvent extraction system. J Ind Eng Chem Res, in press
67. Mammucari R, Dehghani F, Foster NR. Co-precipitation of pharmaceutical using gas anti-solvent techniques. In: 8th Meeting on Supercritical Fluids Chemical Reactivity and Material Processing in Supercritical Fluids, April 14–17, Bordeaux, France; 2002. p. 321–6
68. Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology10.1007/BF02830616 ↗
69. Kwon Y, Won D, Lee S, Hwang S. Preparation of bupivacaine loaded poly (l-lactic acid) microspheres by supercritical fluid processing. In: Proceeding of the American Association of Pharmaceutical Scientist Meeting and Exposition, 10–14 November, Toronto, Canada; 2002
70. Manning MC, Biggs DL, Ng KL, Randolph TW, Hybertson BM. Biodistribution of poly(l-lactic acid) microparticles after intranasal delivery. In: Proceeding of the American Association of Pharmaceutical Scientist Meeting and Exposition, 10–14 November, Toronto, Canada; 2002
71. York P, Wilkins SA, Storey RA, Walker SE, Harland RS. Co-formulation methods and their products. In: PCT Int Appl; 2001, WO0115664
72. Bisrat M, Moshashaee S. Budesonide particles and pharmaceutical compositions containing them. In: PCT Int Appl; 2002, US 6346523
73. Characterisation of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids10.1023/A:1011000915769 ↗